Rapid improvement in walking abilities, more than ten years after stroke following the INR’s patented local etanercept treatment is documented. Discussion is by the patient’s son, a physician, who witnessed the treatment and the rapid response within minutes. The physician narrator is the director of emergency medical services at a well-known South Florida hospital for 25 years. He brought his mother to the Institute of Neurological Recovery in Boca Raton to receive the INR’s patented stroke treatment ten years after her stroke. Following treatment she was able to walk without a walker for the first time since her stroke.
Individual results can vary. Chronic neurological dysfunction produced by stroke has long been thought to be irreversible. A new scientific discovery by the INR, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.
This new patented treatment is exclusively available from INR trained physicians and is available at the INR now at the following locations:
100 UCLA Medical Plaza, Suites 205-210, Los Angeles, California 90095. Appointments: (310) 824-6199.
361 Hospital Road, Suite 428, Newport Beach, California 92663. Appointments: (949) 574-8566.
2300 Glades Road, Suite 305E, Boca Raton, Florida 33431. Appointments: (561) 353-9707.
For further information, please see strokebreakthrough.com.
Please see Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. Edward Tobinick MD. CNS Drugs. 2011 Feb;25(2):145-155.
Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. Anti-TNF treatment for this indication is off-label. Please see the Terms of Use. The method of local etanercept treatment utilized is a patented invention of the INR. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311 and Australian patent 758523.